KALV
KalVista Pharmaceuticals Inc.
$10.91
-$0.06(-0.55%)
29
Overall
40
Value
18
Tech
--
Quality
Market Cap
$562.32M
Volume
856.47K
52W Range
$7.30 - $17.28
Target Price
$30.67
EPS Estimates Overview
| Current Quarter | $-0.96 | Next Quarter | $-0.85 |
| Current Year | $-2.94 | Next Year | $-2.76 |
| QoQ Growth | +11.5% | YoY Growth | +6.1% |
| 3Y EPS CAGR | -3.2% | Target Price | $30.67 |
| Consensus | Buy | Upside | +181.1% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KALV | $10.91 | -0.5% | 856.47K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get KalVista Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW